Stocktoria

NextCure, Inc. NXTC

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2019-05-09 · LEI

NextCure, Inc. statistics & valuation

Market cap$5.9M
P / B0.2×
Return on equity-159.8%
Return on capital-145.4%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
20182019202020212022202320242025
Operating margin (%)
-590.50% -184.20% 20182019202020212022202320242025
Return on equity (%)
-10.50% -12.50% -29.70% -44.60% -54.80% -85.00% -159.80% 20182019202020212022202320242025
Shares outstanding
1.4M 27.5M 27.6M 27.7M 27.8M 27.9M 2.3M 3.5M 20182019202020212022202320242025
Net debt ($)
-$134.7M -$29.1M -$29.3M -$12.3M -$26.6M 20182019202020212022202320242025
Share buybacks ($)
20182019202020212022202320242025
Return on assets (%)
-15.40% -9.50% -11.90% -28.60% -40.60% -49.00% -68.80% -111.30% 20182019202020212022202320242025
Free cash flow margin (%)
-614.40% -232.80% 20182019202020212022202320242025
Debt / equity (×)
0.02× 0.01× 0.00× 0.00× 20182019202020212022202320242025
EPS ($)
-$1.33 -$2.51 -$2.69 -$2.25 -$23.88 -$19.65 20182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Operating margin—————-184.2%-590.5%—
Net margin—————-163.6%-531.5%—
FCF margin—————-232.8%-614.4%—
Return on assets-111.3%-68.8%-49.0%-40.6%-28.6%-11.9%-9.5%-15.4%
Return on equity-159.8%-85.0%-54.8%-44.6%-29.7%-12.5%-10.5%48.6%
Debt / equity———0.00×0.00×0.01×0.02×-0.01×
Current ratio4.147.5016.3817.9734.4827.8922.6013.19

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.